COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,426 Articles (22,835 medRxiv, 8,591 bioRxiv)

Most recent first Previous |  Page 1111: Articles 11101-11110  | Next

Estimating area-level variation in SARS-CoV-2 infection fatality ratios
Ladau, J., Kuo, C., Brodie, E. L., Falco, N., Bansal, I., Hoffman, E. B., Joachimiak, M. P., Mora, A. M., Walker, A. M., Wainwright, H. M., Wu, Y., Jacobson, D., Hess, M., Brown, J. B., Abuabara, K.
10.1101/2021.12.04.21267288 — Posted: 2021-12-05
Persistent Symptoms Among Frontline Health Workers Post-acute COVID-19 Infection
WOSE KINGE, C., HANEKOM, S., LUPTON-SMITH, A., AKPAN, F., MOTHIBI, E., MAOTOE, T., LEBATIE, F., MAJUBA, P., SANNE, I., CHASELA, C.
10.1101/2021.12.03.21267225 — Posted: 2021-12-05
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
Klink, G. V., Safina, K. R., Nabieva, E., Shvyrev, N., Garushyants, S., Alekseeva, E. I., Komissarov, A. B., Danilenko, D. M., Pochtovyy, A. A., Divisenko, E. V., Vasilchenko, L. A., Shidlovskaya, E. V., Kuznetsova, N. A., The Coronavirus Russian Genetics Initiative (CoRGI) Consortium, , Samoilov, A. E., Neverov, A., Popova, A., Fedonin, G., The CRIE Consortium, , Akimkin, V. G., Lioznov, D., Gushchin, V., Shchur, V., Bazykin, G. A.
10.1101/2021.12.02.21267168 — Posted: 2021-12-05
Impact of individual-level characteristics and transmission mitigation behaviors on SARS-CoV-2 infection and seroprevalence in a large Northern California Bay Area cohort
Adams, C., Horton, M., Solomon, O., Wong, M., Wu, S. L., Fuller, S., Shao, X., Fedrigo, I., Quach, H., Quach, D., Meas, M., Lopez, L., Broughton, A., Barcellos, A. L., Shim, J., Seymens, Y., Hernandez, S., Montoya, M., Johnson, D. M., Beckman, K., Busch, M. P., Coloma, J., Lewnard, J., Harris, E., Barcellos, L. F.
10.1101/2021.12.02.21266871 — Posted: 2021-12-05 Discussion: Onsite
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Mohanraj, D., Baldwin, S., Singh, S., Gordon, A., Whitelegg, A.
10.1101/2021.12.03.21267250 — Posted: 2021-12-05 Discussion: Onsite
Underlying co morbidity reveals unique immune signatures in Type II diabetes patients infected with SARS-CoV2
Sengupta, S., Bhattacharya, G., Chatterjee, S., Datey, A., Shaw, S. K., Suranjika, S., Nath, P., Barik, P. K., Prasad, P., PARIDA, A., Chattopadhyay, S., Swain, R. K., DEVADAS, S.
10.1101/2021.12.03.21267282 — Posted: 2021-12-05
Comparative magnitude and persistence of SARS-CoV-2 vaccination responses on a population level in Germany
Dulovic, A., Kessel, B., Harries, M., Becker, M., Ortmann, J., Griesbaum, J., Juengling, J., Junker, D., Hernandez, P., Gornyk, D., Gloeckner, S., Melhorn, V., Castell, S., Heise, J.-K., Kemmling, Y., Tonn, T., Frank, K., Illig, T., Klopp, N., Warikoo, N., Rath, A., Suckel, C., Marzian, A. U., Grupe, N., Kaiser, P. D., Traenkle, B., Rothbauer, U., Kerrinnes, T., Krause, G., Lange, B., Schneiderhan-Marra, N., Strengert, M.
10.1101/2021.12.01.21266960 — Posted: 2021-12-05
Estimation of heterogeneous instantaneous reproduction numbers with application to characterize SARS-CoV-2 transmission in Massachusetts counties
Zhou, Z., Kolaczyk, E., Thompson, R. N., White, L. N.
10.1101/2021.12.02.21267164 — Posted: 2021-12-05
Prevalence of SARS-CoV-2 infection among COVID-19 RT-PCR laboratory workers in Bangladesh
Khan, M. J. R., shumu, S. J., Raihan, R., Mannan, N., Reza, M. S., Khan, N. H., Bhuiyan, A. H., Deb, P., Mim, F., Akram, A.
10.1101/2021.12.02.21267191 — Posted: 2021-12-05
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic: repeated cross-sectional population-based surveys
Godbout, A., Drolet, M., Mondor, M., Simard, M., Sauvageau, C., De Serres, G., Brisson, M.
10.1101/2021.12.02.21267205 — Posted: 2021-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).